Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Don Des Jarlais

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Activities & Behaviors

Disorders

Geographic Areas

Organizations

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Des Jarlais Don C; Arasteh Kamyar; Hagan Holly; McKnight Courtney; Perlman David C; Friedman Samuel R
Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs.
Des Jarlais Don C; McKnight Courtney; Goldblatt Cullen; Purchase David
Doing harm reduction better: syringe exchange in the United States.
Arasteh Kamyar; Des Jarlais Don C
At-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Don Des Jarlais (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Des Jarlais Don C; Arasteh Kamyar; Hagan Holly; McKnight Courtney; Perlman David C; Friedman Samuel R
Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs.
American journal of public health 2009;99 Suppl 2():S445-51.
2009: Des Jarlais Don C; McKnight Courtney; Goldblatt Cullen; Purchase David
Doing harm reduction better: syringe exchange in the United States.
Addiction (Abingdon, England) 2009;104(9):1441-6.
2009: Arasteh Kamyar; Des Jarlais Don C
At-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City.
AIDS patient care and STDs 2009;23(8):657-61.
2009: Des Jarlais Don C; Arasteh Kamyar; Semaan Salaam; Wood Evan
HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities.
Current opinion in HIV and AIDS 2009;4(4):308-13.
2009: Edlin Brian R; Shu Marla A; Winkelstein Emily; Des Jarlais Don C; Busch Michael P; Rehermann Barbara; O'Brien Thomas R; Talal Andrew H; Tobler Leslie H; Zeremski Marija; Beeder Ann B
More rare birds, and the occasional swan.
Gastroenterology 2009;136(7):2412-4.
2009: Arasteh Kamyar; Des Jarlais Don C
HIV testing and treatment among at-risk drinking injection drug users.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 2009;8(3):196-201.
2009: Cooper Hannah L F; Bossak Brian; Tempalski Barbara; Des Jarlais Don C; Friedman Samuel R
Geographic approaches to quantifying the risk environment: drug-related law enforcement and access to syringe exchange programmes.
The International journal on drug policy 2009;20(3):217-26.
2009: Des Jarlais Don C; Arasteh Kamyar; McKnight Courtney; Hagan Holly; Perlman David; Friedman Samuel R
Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.
Drug and alcohol dependence 2009;101(1-2):88-91.
2009: Des Jarlais D C; Semaan S
HIV prevention and psychoactive drug use: a research agenda.
Journal of epidemiology and community health 2009;63(3):191-6.
2009: Vorobjov Sigrid; Uusküla Anneli; Abel-Ollo Katri; Talu Ave; Rüütel Kristi; Des Jarlais Don C
Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.
Harm reduction journal 2009;6():3.
2008: Des Jarlais Don C; Arasteh Kamyar; Hagan Holly
Evaluating Vancouver's supervised injection facility: data and dollars, symbols and ethics.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2008;179(11):1105-6.
2008: Hagan Holly; Pouget Enrique R; Des Jarlais Don C; Lelutiu-Weinberger Corina
Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.
American journal of epidemiology 2008;168(10):1099-109.
2008: Arasteh Kamyar; Des Jarlais Don C
Injecting drug use, HIV, and what to do about it.
Lancet 2008;372(9651):1709-10.
2008: West Stephen G; Duan Naihua; Pequegnat Willo; Gaist Paul; Des Jarlais Don C; Holtgrave David; Szapocznik José; Fishbein Martin; Rapkin Bruce; Clatts Michael; Mullen Patricia Dolan
Alternatives to the randomized controlled trial.
American journal of public health 2008;98(8):1359-66.
2008: Nandi Arijit; Tracy Melissa; Aiello Allison; Des Jarlais Don C; Galea Sandro
Social support and response to AIDS and severe acute respiratory syndrome.
Emerging infectious diseases 2008;14(5):825-7.
2008: Des Jarlais Don C
Data and public health decision making on HIV prevention in injection drug users.
Journal of urban health : bulletin of the New York Academy of Medicine 2008;85(3):303-5.
2008: Arasteh Kamyar; Des Jarlais Don C; Perlis Theresa E
Alcohol and HIV sexual risk behaviors among injection drug users.
Drug and alcohol dependence 2008;95(1-2):54-61.
2008: Tempalski Barbara; Cooper Hannah L; Friedman Samuel R; Des Jarlais Don C; Brady Joanne; Gostnell Karla
Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
The International journal on drug policy 2008;19 Suppl 1():S47-58.
2008: Quaglio Gianluca; Lugoboni Fabio; Pattaro Cristian; Melara Barbara; Mezzelani Paolo; Des Jarlais Don C;
Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment.
Drug and alcohol dependence 2008;94(1-3):12-8.
2008: Hammett Theodore M; Wu Zunyou; Duc Tran Tien; Stephens David; Sullivan Sheena; Liu Wei; Chen Yi; Ngu Doan; Des Jarlais Don C
'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
Addiction (Abingdon, England) 2008;103(1):137-45.
2008: Friedman Samuel R; Mateu-Gelabert Pedro; Sandoval Milagros; Hagan Holly; Des Jarlais Don C
Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection.
BMC public health 2008;8():94.
2007: Des Jarlais Don C; Kling Ryan; Hammett Theodore M; Ngu Doan; Liu Wei; Chen Yi; Binh Kieu Thanh; Friedmann Patricia
Reducing HIV infection among new injecting drug users in the China-Vietnam Cross Border Project.
AIDS (London, England) 2007;21 Suppl 8():S109-14.
2007: Friedman Samuel R; Tempalski Barbara; Brady Joanne E; Friedman Judith J; Cooper Hannah L F; Flom Peter L; McGrath Moriah M; Gostnell Karla; Des Jarlais Don C
Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America.
The International journal on drug policy 2007;18(6):475-85.
2007: Des Jarlais Don C; Hagan Holly; Arasteh Kamyar; McKnight Courtney; Perlman David; Friedman Samuel R
Herpes simplex virus-2 and HIV among noninjecting drug users in New York city.
Sexually transmitted diseases 2007;34(11):923-7.
2007: Des Jarlais Don C; Braine Naomi; Friedmann Patricia
Unstable housing as a factor for increased injection risk behavior at US syringe exchange programs.
AIDS and behavior 2007;11(6 Suppl):78-84.
2007: Hagan Holly; Des Jarlais Don C; Stern Rebecca; Lelutiu-Weinberger Corina; Scheinmann Roberta; Strauss Shiela; Flom Peter L
HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection.
The International journal on drug policy 2007;18(5):341-51.
2007: DES Jarlais Don
Reducing syringe sharing among injecting drug users in Winnipeg: 81% success or 19% failure?
Addiction (Abingdon, England) 2007;102(10):1636.
2007: Des Jarlais Don C
Preventing HIV transmission among injecting drug users (IDUs) and from IDUs to noninjecting sexual partners in Sichuan, China.
Sexually transmitted diseases 2007;34(8):583-5.
2007: Neaigus Alan; Gyarmathy V Anna; Miller Maureen; Frajzyngier Vera; Zhao Mingfang; Friedman Samuel R; Des Jarlais Don C
Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors.
Drug and alcohol dependence 2007;89(2-3):234-43.
2007: Scheinmann Roberta; Hagan Holly; Lelutiu-Weinberger Corina; Stern Rebecca; Des Jarlais Don C; Flom Peter L; Strauss Shiela
Non-injection drug use and Hepatitis C Virus: a systematic review.
Drug and alcohol dependence 2007;89(1):1-12.
2007: Des Jarlais Don C; Arasteh Kamyar; Perlis Theresa; Hagan Holly; Heckathorn Douglas D; Mcknight Courtney; Bramson Heidi; Friedman Samuel R
The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
Addiction (Abingdon, England) 2007;102(5):778-85.
2007: Des Jarlais Don C; Braine Naomi; Yi Huso; Turner Charles
Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs.
AIDS education and prevention : official publication of the International Society for AIDS Education 2007;19(2):111-23.
2007: Masson Carmen L; Sorensen James L; Perlman David C; Shopshire Michael S; Delucchi Kevin L; Chen TeChieh; Sporer Karl; Des Jarlais Don; Hall Sharon M
Hospital- versus community-based syringe exchange: a randomized controlled trial.
AIDS education and prevention : official publication of the International Society for AIDS Education 2007;19(2):97-110.
2007: Neaigus Alan; Gyarmathy V Anna; Zhao Mingfang; Miller Maureen; Friedman Samuel R; Des Jarlais Don C
Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users.
The Journal of infectious diseases 2007;195(7):1052-61.
2007: Cleland Charles M; Deren Sherry; Fuller Crystal M; Blaney Shannon; McMahon James M; Tortu Stephanie; Des Jarlais Don C; Vlahov David
Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program.
Health education & behavior : the official publication of the Society for Public Health Education 2007;34(2):390-403.
2007: Friedman Samuel R; de Jong Wouter; Rossi Diana; Touzé Graciela; Rockwell Russell; Des Jarlais Don C; Elovich Richard
Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups.
The International journal on drug policy 2007;18(2):107-17.
2007: Tempalski Barbara; Flom Peter L; Friedman Samuel R; Des Jarlais Don C; Friedman Judith J; McKnight Courtney; Friedman Risa
Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas.
American journal of public health 2007;97(3):437-47.
2007: Des Jarlais Don C; Arasteh Kamyar; Perlis Theresa; Hagan Holly; Abdul-Quader Abu; Heckathorn Douglas D; McKnight Courtney; Bramson Heidi; Nemeth Chris; Torian Lucia V; Friedman Samuel R
Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
AIDS (London, England) 2007;21(2):231-5.
2007: Cleland Charles M; Des Jarlais Don C; Perlis Theresa E; Stimson Gerry; Poznyak Vladimir;
HIV risk behaviors among female IDUs in developing and transitional countries.
BMC public health 2007;7():271.
2007: Strauss Shiela M; Astone-Twerell Janetta M; Munoz-Plaza Corrine; Des Jarlais Don C; Gwadz Marya; Hagan Holly; Osborne Andrew; Rosenblum Andrew
Correlates of drug treatment program staff's self efficacy to support their clients' hepatitis C virus (HCV) related needs.
The American journal of drug and alcohol abuse 2007;33(2):245-51.
2007: Strauss Shiela M; Astone-Twerell Janetta; Munoz-Plaza Corrine E; Des Jarlais Don C; Gwadz Marya; Hagan Holly; Osborne Andrew; Rosenblum Andrew
Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services.
BMC health services research 2007;7():39.
2006: Semaan Salaam; Des Jarlais Don C; Bice Steve
Sexual health in art and science.
Emerging infectious diseases 2006;12(11):1782-8.
2006: McKnight Courtney; Des Jarlais Don; Bramson Heidi; Tower Lisa; Abdul-Quader Abu S; Nemeth Chris; Heckathorn Douglas
Respondent-driven sampling in a study of drug users in New York City: notes from the field.
Journal of urban health : bulletin of the New York Academy of Medicine 2006;83(6 Suppl):i54-9.
2006: Deren Sherry; Cleland Charles M; Fuller Crystal; Kang Sung-Yeon; Des Jarlais Don C; Vlahov David
The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings.
AIDS and behavior 2006;10(6):717-21.
2006: Munoz-Plaza Corrine E; Strauss Shiela M; Astone-Twerwll Janetta M; Des Jarlais Don C; Hagan Holly
Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs.
Journal of psychoactive drugs 2006;38(3):233-41.
2006: Vassilev Z P; Hagan H; Lyubenova A; Tomov N; Vasilev G; Krasteva D; Des Jarlais D C
Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
International journal of STD & AIDS 2006;17(9):621-6.
2006: Des Jarlais Don C; Sloboda Zili; Friedman Samuel R; Tempalski Barbara; McKnight Courtney; Braine Naomi
Diffusion of the D.A.R.E and syringe exchange programs.
American journal of public health 2006;96(8):1354-8.
2006: Des Jarlais Don C
Mathilde Krim, amfAR, and the prevention of HIV infection among injecting drug users: a brief history.
AIDS patient care and STDs 2006;20(7):467-71.
2006: Strauss Shiela M; Rindskopf David M; Astone-Twerell Janetta M; Des Jarlais Don C; Hagan Holly
Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S.
Drug and alcohol dependence 2006;83(1):15-24.
2006: Abdul-Quader Abu S; Heckathorn Douglas D; McKnight Courtney; Bramson Heidi; Nemeth Chris; Sabin Keith; Gallagher Kathleen; Des Jarlais Don C
Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study.
Journal of urban health : bulletin of the New York Academy of Medicine 2006;83(3):459-76.
2006: Neaigus Alan; Gyarmathy V Anna; Miller Maureen; Frajzyngier Veronica M; Friedman Samuel R; Des Jarlais Don C
Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility.
Journal of acquired immune deficiency syndromes (1999) 2006;41(4):493-503.
2006: Quaglio Gianluca; Lugoboni Fabio; Mezzelani Paolo; Des Jarlais Don C; Lechi Alessandro
Hepatitis vaccination among drug users.
Vaccine 2006;24(15):2702-9.
2006: Des Jarlais Don C; Galea Sandro; Tracy Melissa; Tross Susan; Vlahov David
Stigmatization of newly emerging infectious diseases: AIDS and SARS.
American journal of public health 2006;96(3):561-7.
2006: Friedman Samuel R; Cooper Hannah Lf; Tempalski Barbara; Keem Maria; Friedman Risa; Flom Peter L; Des Jarlais Don C
Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas.
AIDS (London, England) 2006;20(1):93-9.
2006: Strauss Shiela M; Astone-Twerell Janetta M; Munoz-Plaza Corrine; Des Jarlais Don C; Gwadz Marya; Hagan Holly; Osborne Andrew; Rosenblum Andrew
Hepatitis C knowledge among staff in U.S. drug treatment programs.
Journal of drug education 2006;36(2):141-58.
2006: Semaan Salaam; Des Jarlais Don C; Malow Rob
Behavior change and health-related interventions for heterosexual risk reduction among drug users.
Substance use & misuse 2006;41(10-12):1349-78.
2006: Quaglio Gianluca; Lugoboni Fabio; Pattaro Cristian; Montanari Linda; Lechi Alessandro; Mezzelani Paolo; Des Jarlais Don C
Patients in long-term maintenance therapy for drug use in Italy: analysis of some parameters of social integration and serological status for infectious diseases in a cohort of 1091 patients.
BMC public health 2006;6():216.
2006: Des Jarlais Don C; Perlis Theresa E; Stimson Gerry V; Poznyak Vladimir;
Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II.
BMC public health 2006;6():54.
2005: Braine Naomi; Des Jarlais Don C; Goldblatt Cullen; Zadoretzky Cathy; Turner Charles
HIV risk behavior among amphetamine injectors at U.S. syringe exchange programs.
AIDS education and prevention : official publication of the International Society for AIDS Education 2005;17(6):515-24.
2005: Des Jarlais Don C; Stuber Jennifer; Tracy Melissa; Tross Susan; Galea Sandro
Social factors associated with AIDS and SARS.
Emerging infectious diseases 2005;11(11):1767-9.
2005: Des Jarlais Don C
Evaluating national harm reduction programs.
Addiction (Abingdon, England) 2005;100(11):1575-6.
2005: Des Jarlais Don C; Lyles Cynthia M; Crepaz Nicole
Re: "quality of reporting of observational longitudinal research".
American journal of epidemiology 2005;162(10):1032; author reply 1033.
2005: Des Jarlais Don C; Perlis Theresa; Arasteh Kamyar; Torian Lucia V; Hagan Holly; Beatrice Sara; Smith Lou; Wethers Judith; Milliken Judith; Mildvan Donna; Yancovitz Stanley; Friedman Samuel R
Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.
AIDS (London, England) 2005;19 Suppl 3():S20-5.
2005: Hagan Holly; Thiede Hanne; Des Jarlais Don C
HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention.
AIDS (London, England) 2005;19 Suppl 3():S199-207.
2005: Lugoboni Fabio; Quaglio Gianluca; Pajusco Benedetta; Foroni Maurizio; Blengio Gianstefano; Talamini Giorgio; Mezzelani Paolo; Des Jarlais Don C
Prevalence of hepatitis A among drug users in north-eastern Italy. Is vaccination necessary in low prevalence areas?
European journal of public health 2005;15(5):464-6.
2005: Hammett Theodore M; Norton Giulia D; Kling Ryan; Liu Wei; Chen Yi; Ngu Doan; Binh Kieu Thanh; Dong Ha Viet; Des Jarlais Don C
Community attitudes toward HIV prevention for injection drug users: findings from a cross-border project in southern China and northern Vietnam.
Journal of urban health : bulletin of the New York Academy of Medicine 2005;82(3 Suppl 4):iv34-42.
2005: Kottiri Benny J; Friedman Samuel R; Euler Gary L; Flom Peter L; Sandoval Milagros; Neaigus Alan; Des Jarlais Don C; Zenilman Jonathan M
A community-based study of hepatitis B infection and immunization among young adults in a high-drug-use neighborhood in New York City.
Journal of urban health : bulletin of the New York Academy of Medicine 2005;82(3):479-87.
2005: Pouget Enrique R; Deren Sherry; Fuller Crystal M; Blaney Shannon; McMahon James M; Kang Sung-Yeon; Tortu Stephanie; Andia Jonny F; Des Jarlais Don C; Vlahov David
Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program.
Journal of acquired immune deficiency syndromes (1999) 2005;39(4):471-7.
2005: Des Jarlais Don C; Perlis Theresa; Arasteh Kamyar; Torian Lucia V; Beatrice Sara; Milliken Judith; Mildvan Donna; Yancovitz Stanley; Friedman Samuel R
HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services.
American journal of public health 2005;95(8):1439-44.
2005: Carey Jeanne; Perlman David C; Friedmann Patricia; Kaplan Wendy M; Nugent Ann; Deutscher Meredith; Masson Carmen L; Des Jarlais Don C
Knowledge of hepatitis among active drug injectors at a syringe exchange program.
Journal of substance abuse treatment 2005;29(1):47-53.
2005: Hagan Holly; Strauss Shiela M; Astone Janetta M; Des Jarlais Don C
Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40 Suppl 5():S297-303.
2005: Strauss Shiela M; Astone Janetta M; Des Jarlais Don C; Hagan Holly
Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units.
AIDS patient care and STDs 2005;19(2):78-88.
2005: Hammett Theodore M; Johnston Patrick; Kling Ryan; Liu Wei; Ngu Doan; Tung Nguyen Duy; Binh Kieu Thanh; Dong Ha Viet; Hoang Tran Vu; Van Ly Kieu; Donghua Meng; Chen Yi; Des Jarlais Don C
Correlates of HIV status among injection drug users in a border region of southern China and northern Vietnam.
Journal of acquired immune deficiency syndromes (1999) 2005;38(2):228-35.
2005: Des Jarlais Don C; Perlis Theresa E; Settembrino Joy M
The use of electronic debit cards in longitudinal data collection with geographically mobile drug users.
Drug and alcohol dependence 2005;77(1):1-5.
2005: Strauss Shiela M; Astone Janetta M; Munoz-Plaza Corrine; Hagan Holly; Des Jarlais Don
Residential substance user treatment programs as venues for HCV pharmacological treatment: client and staff perspectives.
Substance use & misuse 2005;40(12):1811-29.
2005: Des Jarlais Don C; Johnston Patrick; Friedmann Patricia; Kling Ryan; Liu Wei; Ngu Doan; Chen Yi; Hoang Tran V; Donghua Meng; Van Ly K; Tung Nguyen D; Binh Kieu T; Hammett Theodore M
Patterns of HIV prevalence among injecting drug users in the cross-border area of Lang Son Province, Vietnam, and Ning Ming County, Guangxi Province, China.
BMC public health 2005;5():89.
2004: Kuo Wen-Hung; Wilson Tracey E; Weber Kathleen M; Madhava Valsa; Richardson Jean; Delapenha Robert; Des Jarlais Don
Initiation of regular marijuana use among a cohort of women infected with or at risk for HIV in the Women's Interagency HIV Study (WIHS).
AIDS patient care and STDs 2004;18(12):702-13.
2004: Astone Janetta M; Strauss Shiela M; Hagan Holly; Des Jarlais Don C
Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services.
The American journal of drug and alcohol abuse 2004;30(4):783-97.
2004: Vassilev Zdravko P; Strauss Shiela M; Astone Janetta M; Friedmann Peter D; Des Jarlais Don C
Provision of on-site medical care to patients with hepatitis C in drug treatment units.
Journal of health care for the poor and underserved 2004;15(4):663-71.
2004: Des Jarlais Don C; Hammett Theodore M; Wei Lui; Van Ly Kieu; Donghua Meng; Ngu Doan
Opiate agonist maintenance treatment for injecting drug user peer educators.
Addiction (Abingdon, England) 2004;99(10):1355-6.
2004: Vanichseni Suphak; Des Jarlais Don C; Choopanya Kachit; Mock Philip A; Kitayaporn Dwip; Sangkhum Udomsak; Prasithiphol Boonrawd; Hu Dale J; van Griensven Frits; Mastro Timothy D; Tappero Jordan W
Sexual risk reduction in a cohort of injecting drug users in Bangkok, Thailand.
Journal of acquired immune deficiency syndromes (1999) 2004;37(1):1170-9.
2004: Des Jarlais Don C; Braine Naomi
Assessing syringe exchange programs.
Addiction (Abingdon, England) 2004;99(9):1081-2.
2004: Hagan Holly; Thiede Hanne; Des Jarlais Don C
Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion.
Epidemiology (Cambridge, Mass.) 2004;15(5):543-9.
2004: Havens Jennifer R; Strathdee Steffanie A; Fuller Crystal M; Ikeda Robin; Friedman Samuel R; Des Jarlais Don C; Morse Patricia S; Bailey Susan; Kerndt Peter; Garfein Richard S;
Correlates of attempted suicide among young injection drug users in a multi-site cohort.
Drug and alcohol dependence 2004;75(3):261-9.
2004: Becker Buxton Meredith; Vlahov David; Strathdee Steffanie A; Des Jarlais Don C; Morse Edward V; Ouellet Lawrence; Kerndt Peter; Garfein Richard S
Association between injection practices and duration of injection among recently initiated injection drug users.
Drug and alcohol dependence 2004;75(2):177-83.
2004: Perlis Theresa E; Des Jarlais Don C; Friedman Samuel R; Arasteh Kamyar; Turner Charles F
Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs.
Addiction (Abingdon, England) 2004;99(7):885-96.
2004: Braine Naomi; Des Jarlais Don C; Ahmad Seema; Purchase Dave; Turner Charles
Long-term effects of syringe exchange on risk behavior and HIV prevention.
AIDS education and prevention : official publication of the International Society for AIDS Education 2004;16(3):264-75.
2004: Garfein Richard S; Monterroso Edgar R; Tong Tony C; Vlahov David; Des Jarlais Don C; Selwyn Peter; Kerndt Peter R; Word Carl; Fernando M Daniel; Ouellet Lawrence J; Holmberg Scott D
Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities.
Journal of urban health : bulletin of the New York Academy of Medicine 2004;81(2):260-7.
2004: Vassilev Zdravko P; Strauss Shiela M; Astone Janetta; Des Jarlais Don C
Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs.
The journal of behavioral health services & research 2004;31(2):208-16.
2004: Quaglio Gianluca; Pajusco Benedetta; Civitelli Paolo; Migliozzi Sabrina; Des Jarlais Don C; Romanò Luisa; Lechi Alessandro; Mezzelani Paolo; Lugoboni Fabio
Immunogenicity, reactogenicity and adherence with hepatitis A vaccination among drug users.
Drug and alcohol dependence 2004;74(1):85-8.
2004: Des Jarlais Don C; McKnight Courtney; Milliken Judith
Public funding of US syringe exchange programs.
Journal of urban health : bulletin of the New York Academy of Medicine 2004;81(1):118-21.
2004: Strauss Shiela M; Astone Janetta M; Hagan Holly; Des Jarlais Don C
The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units.
Journal of urban health : bulletin of the New York Academy of Medicine 2004;81(1):38-47.
2004: Vlahov David; Fuller Crystal M; Ompad Danielle C; Galea Sandro; Des Jarlais Don C
Updating the infection risk reduction hierarchy: preventing transition into injection.
Journal of urban health : bulletin of the New York Academy of Medicine 2004;81(1):14-9.
2004: Des Jarlais Don C; Lyles Cynthia; Crepaz Nicole;
Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement.
American journal of public health 2004;94(3):361-6.
2004: Des Jarlais Don C; Perlis Theresa; Arasteh Kamyar; Hagan Holly; Milliken Judith; Braine Naomi; Yancovitz Stanley; Mildvan Donna; Perlman David C; Maslow Carey; Friedman Samuel R
"Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.
Journal of acquired immune deficiency syndromes (1999) 2004;35(2):158-66.
2004: Fuller Crystal M; Galea Sandro; Blaney Shannon; Ompad Danielle C; Deren Sherry; Des Jarlais Don; Vlahov David
Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City.
Ethnicity & disease 2004;14(4):589-96.
2003: Quaglio G L; Lugoboni F; Pajusco B; Sarti M; Talamini G; Mezzelani P; Des Jarlais D C;
Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy.
Journal of viral hepatitis 2003;10(5):394-400.
2003: Perlman David C; Friedmann Patricia; Horn Leslie; Nugent Anne; Schoeb Veronika; Carey Jeanne; Salomon Nadim; Des Jarlais Don C
Impact of monetary incentives on adherence to referral for screening chest x-rays after syringe exchange-based tuberculin skin testing.
Journal of urban health : bulletin of the New York Academy of Medicine 2003;80(3):428-37.
2003: Quaglio Gianluca; Lugoboni Fabio; Pajusco Benedetta; Sarti Maddalena; Talamini Giorgio; Lechi Alessandro; Mezzelani Paolo; Des Jarlais Don C
Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(1):33-40.
2003: Strauss Shiela M; Astone Janetta; Vassilev Zdravko P; Des Jarlais Don C; Hagan Holly
Gaps in the drug-free and methadone treatment program response to Hepatitis C.
Journal of substance abuse treatment 2003;24(4):291-7.
2003: Friedman Samuel R; Ompad Danielle C; Maslow Carey; Young Rebecca; Case Patricia; Hudson Sharon M; Diaz Theresa; Morse Edward; Bailey Susan; Des Jarlais Don C; Perlis Theresa; Hollibaugh Amber; Garfein Richard S
HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women.
American journal of public health 2003;93(6):902-6.
2003: Choopanya Kachit; Des Jarlais Don C; Vanichseni Suphak; Mock Philip A; Kitayaporn Dwip; Sangkhum Udomsak; Prasithiphol Boonrawd; Hiranrus Krit; van Griensven Frits; Tappero Jordan W; Mastro Timothy D
HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand.
Journal of acquired immune deficiency syndromes (1999) 2003;33(1):88-95.
2003: Des Jarlais Don C; Diaz Theresa; Perlis Theresa; Vlahov David; Maslow Carey; Latka Mary; Rockwell Russell; Edwards Vincent; Friedman Samuel R; Monterroso Edgar; Williams Ian; Garfein Richard S
Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City.
American journal of epidemiology 2003;157(5):467-71.
2003: Friedman Samuel R; Flom Peter L; Kottiri Benny J; Zenilman Jonathan; Curtis Richard; Neaigus Alan; Sandoval Milagros; Quinn Thomas; Des Jarlais Don C
Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City.
Addiction (Abingdon, England) 2003;98(2):159-69.
2003: Strauss Shiela M; Des Jarlais Don C; Astone Janetta; Vassilev Zdravko P
On-site HIV testing in residential drug treatment units: results of a nationwide survey.
Public health reports (Washington, D.C. : 1974) 2003;118(1):37-43.
2003: Astone Janetta; Strauss Shiela M; Vassilev Zdravko P; Des Jarlais Don C
Provision of hepatitis C education in a nationwide sample of drug treatment programs.
Journal of drug education 2003;33(1):107-17.
2002: Des Jarlais Don C; McKnight Courtney; Friedmann Patricia
Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001.
Journal of the American Pharmaceutical Association (Washington,D.C. : 1996) 2002;42(6 Suppl 2):S73-6.
2002: Feng Cheng; Des Jarlais Don
HIV among drug users in China.
Science (New York, N.Y.) 2002;298(5596):1171; author reply 1171.
2002: Kapadia Farzana; Vlahov David; Des Jarlais Don C; Strathdee Steffanie A; Ouellet Lawrence; Kerndt Peter; Morse E Edward V; Williams Ian; Garfein Richard S;
Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users?
Epidemiology (Cambridge, Mass.) 2002;13(6):738-41.
2002: Friedman S R; Flom P L; Kottiri B J; Neaigus A; Sandoval M; Fuld J; Curtis R; Zenilman J M; Des Jarlais D C
Consistent condom use among drug-using youth in a high HIV-risk neighbourhood.
AIDS care 2002;14(4):493-507.
2002: Gyarmathy V Anna; Neaigus Alan; Miller Maureen; Friedman Samuel R; Des Jarlais Don C
Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users.
Journal of acquired immune deficiency syndromes (1999) 2002;30(4):448-56.
2002: Semaan Salaam; Des Jarlais Don C; Sogolow Ellen; Johnson Wayne D; Hedges Larry V; Ramirez Gilbert; Flores Stephen A; Norman Lisa; Sweat Michael D; Needle Richard
A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States.
Journal of acquired immune deficiency syndromes (1999) 2002;30 Suppl 1():S73-93.
2002: Semaan Salaam; Kay Linda; Strouse Darcy; Sogolow Ellen; Mullen Patricia Dolan; Neumann Mary Spink; Flores Stephen A; Peersman Greet; Johnson Wayne D; Lipman Paula Darby; Eke Agatha; Des Jarlais Don C
A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction.
Journal of acquired immune deficiency syndromes (1999) 2002;30 Suppl 1():S30-50.
2002: Des Jarlais Don C; Semaan Salaam
HIV prevention research: cumulative knowledge or accumulating studies? An introduction to the HIV/AIDS prevention research synthesis project supplement.
Journal of acquired immune deficiency syndromes (1999) 2002;30 Suppl 1():S1-7.
2002: Hu Dale J; Subbarao Shambavi; Vanichseni Suphak; Mock Philip A; van Griensven Frits; Nelson Robert; Nguyen Lily; Kitayaporn Dwip; Young Nancy L; Des Jarlais Don; Byers Robert; Choopanya Kachit; Mastro Timothy D
Higher viral loads and other risk factors associated with HIV-1 seroconversion during a period of high incidence among injection drug users in Bangkok.
Journal of acquired immune deficiency syndromes (1999) 2002;30(2):240-7.
2002: Kottiri Benny J; Friedman Samuel R; Neaigus Alan; Curtis Richard; Des Jarlais Don C
Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users.
Journal of acquired immune deficiency syndromes (1999) 2002;30(1):95-104.
2002: Goldstein Marjorie F; Deren Sherry; Kang Sung Yeon; Des Jarlais Don C; Magura Stephen
Evaluation of an alternative program for MMTP drop-outs: impact on treatment re-entry.
Drug and alcohol dependence 2002;66(2):181-7.
2002: Rockwell Russell; Deren Sherry; Goldstein Marjorie F; Friedman Samuel R; Des Jarlais Don C
Trends in the AIDS epidemic among New York City's injection drug users: localized or citywide?
Journal of urban health : bulletin of the New York Academy of Medicine 2002;79(1):136-46.
2002: Strauss Shiela M; Falkin Gregory P; Vassilev Zdravko; Des Jarlais Don C; Astone Janetta
A nationwide survey of hepatitis C services provided by drug treatment programs.
Journal of substance abuse treatment 2002;22(2):55-62.
2002: Maslow Carey B; Friedman Samuel R; Perlis Theresa E; Rockwell Russell; Des Jarlais Don C
Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999.
American journal of public health 2002;92(3):382-4.
2002: Newman Jessica Clark; Des Jarlais Don C; Turner Charles F; Gribble Jay; Cooley Phillip; Paone Denise
The differential effects of face-to-face and computer interview modes.
American journal of public health 2002;92(2):294-7.
2002: Choopanya Kachit; Des Jarlais Don C; Vanichseni Suphak; Kitayaporn Dwip; Mock Philip A; Raktham Suwanee; Hireanras Krit; Heyward William L; Sujarita Sathit; Mastro Timothy D
Incarceration and risk for HIV infection among injection drug users in Bangkok.
Journal of acquired immune deficiency syndromes (1999) 2002;29(1):86-94.
2001: Des Jarlais D C; Fisher D G; Newman J C; Trubatch B N; Yancovitz M; Paone D; Perlman D
Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program.
American journal of public health 2001;91(11):1791-2.
2001: Flom P L; Friedman S R; Kottiri B J; Neaigus A; Curtis R; Des Jarlais D C; Sandoval M; Zenilman J M
Stigmatized drug use, sexual partner concurrency, and other sex risk network and behavior characteristics of 18- to 24-year-old youth in a high-risk neighborhood.
Sexually transmitted diseases 2001;28(10):598-607.
2001: Friedman S R; Flom P L; Kottiri B J; Neaigus A; Sandoval M; Curtis R; Zenilman J M; Des Jarlais D C
Prevalence and correlates of anal sex with men among young adult women in an inner city minority neighborhood.
AIDS (London, England) 2001;15(15):2057-60.
2001: Perlman D C; Gourevitch M N; Trinh C; Salomon N; Horn L; Des Jarlais D C
Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program.
Journal of urban health : bulletin of the New York Academy of Medicine 2001;78(3):550-67.
2001: Neaigus A; Miller M; Friedman S R; Des Jarlais D C
Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus.
The Journal of infectious diseases 2001;184(3):359-63.
2001: Neaigus A; Miller M; Friedman S R; Hagen D L; Sifaneck S J; Ildefonso G; des Jarlais D C
Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors.
Addiction (Abingdon, England) 2001;96(6):847-60.
2001: Friedman S R; Flom P L; Kottiri B J; Neaigus A; Sandoval M; Curtis R; Des Jarlais D C; Zenilman J M
Consistent condom use in the heterosexual relationships of young adults who live in a high-HIV-risk neighbourhood and do not use "hard drugs".
AIDS care 2001;13(3):285-96.
2001: Friedman S R; Perlis T; Des Jarlais D C
Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence.
American journal of public health 2001;91(5):791-3.
2001: Des Jarlais D C; Dehne K; Casabona J
HIV surveillance among injecting drug users.
AIDS (London, England) 2001;15 Suppl 3():S13-22.
2001: Deren S; Goldstein M F; Des Jarlais D C; Richman B L; Kang S; Flom P L
Drug use, HIV-related risk behaviors and dropout status of new admissions and re-admissions to methadone treatment.
Journal of substance abuse treatment 2001;20(2):185-9.
2001: Vanichseni S; Kitayaporn D; Mastro T D; Mock P A; Raktham S; Des Jarlais D C; Sujarita S; Srisuwanvilai L O; Young N L; Wasi C; Subbarao S; Heyward W L; Esparza L; Choopanya K
Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand.
AIDS (London, England) 2001;15(3):397-405.
2001: Diaz T; Des Jarlais D C; Vlahov D; Perlis T E; Edwards V; Friedman S R; Rockwell R; Hoover D; Williams I T; Monterroso E R
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City.
American journal of public health 2001;91(1):23-30.
2001: Des Jarlais D C; Schuchat A
Hepatitis C among drug users: déjà vu all over again?
American journal of public health 2001;91(1):21-2.
2001: Latka M; Ahern J; Garfein R S; Ouellet L; Kerndt P; Morse P; Farshy C E; Des Jarlais D C; Vlahov D;
Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users.
Journal of substance abuse 2001;13(1-2):73-88.
2000: Friedman S R; Kottiri B J; Neaigus A; Curtis R; Vermund S H; Des Jarlais D C
Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation.
American journal of epidemiology 2000;152(10):913-22.
2000: Galynker I I; Watras-Ganz S; Miner C; Rosenthal R N; Des Jarlais D C; Richman B L; London E
Cerebral metabolism in opiate-dependent subjects: effects of methadone maintenance.
The Mount Sinai journal of medicine, New York 2000;67(5-6):381-7.
2000: Monterroso E R; Hamburger M E; Vlahov D; Des Jarlais D C; Ouellet L J; Altice F L; Byers R H; Kerndt P R; Watters J K; Bowser B P; Fernando M D; Holmberg S D
Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS).
Journal of acquired immune deficiency syndromes (1999) 2000;25(1):63-70.
2000: Des Jarlais D C
Research, politics, and needle exchange.
American journal of public health 2000;90(9):1392-4.
2000: Marmor M; Shore R E; Titus S; Chen X; Des Jarlais D C
Drug injection rates and needle-exchange use in New York City, 1991-1996.
Journal of urban health : bulletin of the New York Academy of Medicine 2000;77(3):359-68.
2000: Des Jarlais D C
Structural interventions to reduce HIV transmission among injecting drug users.
AIDS (London, England) 2000;14 Suppl 1():S41-6.
2000: Des Jarlais D C; Marmor M; Friedmann P; Titus S; Aviles E; Deren S; Torian L; Glebatis D; Murrill C; Monterroso E; Friedman S R
HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic.
American journal of public health 2000;90(3):352-9.
2000: Salomon N; Perlman D C; Friedmann P; Ziluck V; Des Jarlais D C
Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2000;4(1):47-54.
1999: Friedman S R; Chapman T F; Perlis T E; Rockwell R; Paone D; Sotheran J L; Des Jarlais D C
Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996.
Journal of acquired immune deficiency syndromes (1999) 1999;22(1):83-91.
1999: Rockwell R; Des Jarlais D C; Friedman S R; Perlis T E; Paone D
Geographic proximity, policy and utilization of syringe exchange programmes.
AIDS care 1999;11(4):437-42.
1999: MacQueen K M; Vanichseni S; Kitayaporn D; Lin L S; Buavirat A; Naiwatanakul T; Raktham S; Mock P; Heyward W L; Des Jarlais D C; Choopanya K; Mastro T D
Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand.
Journal of acquired immune deficiency syndromes (1999) 1999;21(3):243-51.
1999: Paone D; Cooper H; Alperen J; Shi Q; Des Jarlais D C
HIV risk behaviours of current sex workers attending syringe exchange: the experiences of women in five US cities.
AIDS care 1999;11(3):269-80.
1999: Perlman D C; Henman A R; Kochems L; Paone D; Salomon N; Des Jarlais D C
Doing a shotgun: a drug use practice and its relationship to sexual behaviors and infection risk.
Social science & medicine (1982) 1999;48(10):1441-8.
1999: Des Jarlais D C; Paone D; Milliken J; Turner C F; Miller H; Gribble J; Shi Q; Hagan H; Friedman S R
Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial.
Lancet 1999;353(9165):1657-61.
1999: Friedman S R; Curtis R; Jose B; Flom P L; Neaigus A; Des Jarlais D C
The message not heard: myth and reality in discussions about syringe exchange.
AIDS (London, England) 1999;13(6):738-9.
1999: Des Jarlais D C
Psychoactive drug use and progression of HIV infection.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1999;20(3):272-4.
1999: Paone D; Clark J; Shi Q; Purchase D; Des Jarlais D C
Syringe exchange in the United States, 1996: a national profile.
American journal of public health 1999;89(1):43-6.
1999: Des Jarlais D C; Friedman S R; Perlis T; Chapman T F; Sotheran J L; Paone D; Monterroso E; Neaigus A
Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1999;20(1):67-72.
1999: Des Jarlais D; Caraël M
AIDS 1999. Behavioral and social science: overview.
AIDS (London, England) 1999;13 Suppl A():S235-7.
1998: Vazquez-Levin M H; Goldberg S I; Friedmann P; Des Jarlais D C; Nagler H M
Papanicolaou and Kruger assessment of sperm morphology: thresholds and agreement.
International journal of andrology 1998;21(6):327-31.
1998: Des Jarlais D C; Perlis T; Friedman S R; Deren S; Chapman T; Sotheran J L; Tortu S; Beardsley M; Paone D; Torian L V; Beatrice S T; DeBernardo E; Monterroso E; Marmor M
Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996.
American journal of public health 1998;88(12):1801-6.
1998: Kitayaporn D; Vanichseni S; Mastro T D; Raktham S; Vaniyapongs T; Des Jarlais D C; Wasi C; Young N L; Sujarita S; Heyward W L; Esparza J
Infection with HIV-1 subtypes B and E in injecting drug users screened for enrollment into a prospective cohort in Bangkok, Thailand.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;19(3):289-95.
1998: Friedman S R; Furst R T; Jose B; Curtis R; Neaigus A; Des Jarlais D C; Goldstein M F; Ildefonso G
Drug scene roles and HIV risk.
Addiction (Abingdon, England) 1998;93(9):1403-16.
1998: Henman A R; Paone D; Des Jarlais D C; Kochems L M; Friedman S R
Injection drug users as social actors: a stigmatized community's participation in the syringe exchange programmes of New York City.
AIDS care 1998;10(4):397-408.
1998: Des Jarlais D C
Validity of self-reported data, scientific methods and drug policy.
Drug and alcohol dependence 1998;51(3):265-6.
1998: Des Jarlais D C; Friedman S R
Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done.
Public health reports (Washington, D.C. : 1974) 1998;113 Suppl 1():182-8.
1998: Paone D; Perlman D C; Perkins M P; Kochems L M; Salomon N; Des Jarlais D C
Organizational issues in conducting tuberculosis screening at a syringe exchange program.
Journal of substance abuse treatment 1998;15(3):229-34.
1998: Henman A R; Paone D; Des Jarlais D C; Kochems L M; Friedman S R
From ideology to logistics: the organizational aspects of syringe exchange in a period of institutional consolidation.
Substance use & misuse 1998;33(5):1213-30.
1998: Mezzelani P; Quaglio G L; Venturini L; Lugoboni F; Friedman S R; Des Jarlais D C
A multicentre study on the causes of death among Italian injecting drug users. AIDS has overtaken overdose as the principal cause of death.
AIDS care 1998;10(1):61-7.
1998: Des Jarlais D C
"Single-use" needles and syringes for the prevention of HIV infection among injection drug users.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;18 Suppl 1():S52-6.
1997: Paone D; Des Jarlais D C; Caloir S; Jose B; Shi Q; Friedman S R
Continued risky injection subsequent to syringe exchange use among injection drug users in New York City.
AIDS education and prevention : official publication of the International Society for AIDS Education 1997;9(6):505-10.
1997: Des Jarlais D C; Vanichseni S; Marmor M; Buavirat A; Titus S; Raktham S; Friedmann P; Kitayaporn D; Wolfe H; Friedman S R; Mastro T D
"Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trials.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(5):393-9.
1997: Des Jarlais D C; Padian N
Strategies for universalistic and targeted HIV prevention.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(2):127-36.
1997: Guttmacher S; Lieberman L; Ward D; Freudenberg N; Radosh A; Des Jarlais D
Condom availability in New York City public high schools: relationships to condom use and sexual behavior.
American journal of public health 1997;87(9):1427-33.
1997: Friedman S R; Neaigus A; Jose B; Curtis R; Goldstein M; Ildefonso G; Rothenberg R B; Des Jarlais D C
Sociometric risk networks and risk for HIV infection.
American journal of public health 1997;87(8):1289-96.
1997: Friedman S R; Curtis R; Jose B; Neaigus A; Zenilman J; Culpepper-Morgan J; Borg L; Kreek J; Paone D; Des Jarlais D C
Sex, drugs, and infections among youth. Parenterally and sexually transmitted diseases in a high-risk neighborhood.
Sexually transmitted diseases 1997;24(6):322-6.
1997: Deren S; Shedlin M; Davis W R; Clatts M C; Balcorta S; Beardsley M M; Sanchez J; Des Jarlais D
Dominican, Mexican, and Puerto Rican prostitutes: drug use and sexual behaviors.
Hispanic journal of behavioral sciences 1997;19(2):202-13.
1997: Perlman D C; Perkins M P; Solomon N; Kochems L; Des Jarlais D C; Paone D
Tuberculosis screening at a syringe exchange program.
American journal of public health 1997;87(5):862-3.
1997: Des Jarlais D C; Friedman S R; Hagan H; Paone D; Vlahov D
Drug use. Vancouver Conference Review.
AIDS care 1997;9(1):53-7.
1997: Perlman D C; Perkins M P; Paone D; Kochems L; Salomon N; Friedmann P; Des Jarlais D C
"Shotgunning" as an illicit drug smoking practice.
Journal of substance abuse treatment 1997;14(1):3-9.
1996: Kochems L M; Paone D; Des Jarlais D C; Ness I; Clark J; Friedman S R
The transition from underground to legal syringe exchange: the New York City experience.
AIDS education and prevention : official publication of the International Society for AIDS Education 1996;8(6):471-89.
1996: Des Jarlais D C; Friedmann P; Hagan H; Friedman S R
The protective effect of AIDS-related behavioral change among injection drug users: a cross-national study. WHO Multi-Centre Study of AIDS and Injecting Drug Use.
American journal of public health 1996;86(12):1780-5.
1996: Deren S; Sanchez J; Shedlin M; Davis W R; Beardsley M; Des Jarlais D; Miller K
HIV risk behaviors among Dominican brothel and street prostitutes in New York City.
AIDS education and prevention : official publication of the International Society for AIDS Education 1996;8(5):444-56.
1996: Des Jarlais D C; Marmor M; Paone D; Titus S; Shi Q; Perlis T; Jose B; Friedman S R
HIV incidence among injecting drug users in New York City syringe-exchange programmes.
Lancet 1996;348(9033):987-91.
1996: Marmor M; Titus S; Harrison C; Cord-Cruz E A; Shore R E; Vogler M; Krasinski K; Mildvan D; Des Jarlais D C
Weight loss associated with HIV seroconversion among injection-drug users.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;12(5):514-8.
1996: Shore R E; Marmor M; Titus S; Des Jarlais D C
Methadone maintenance and other factors associated with intraindividual temporal trends in injection-drug use.
Journal of substance abuse treatment 1996;13(3):241-8.
1996: Neaigus A; Friedman S R; Jose B; Goldstein M F; Curtis R; Ildefonso G; Des Jarlais D C
High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(5):499-509.
1996: Grund J P; Friedman S R; Stern L S; Jose B; Neaigus A; Curtis R; Des Jarlais D C
Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens.
Social science & medicine (1982) 1996;42(5):691-703.
1996: Paone D; Des Jarlais D; Clark J; Shi Q
Syringe-exchange programs in the United States: where are we now?
AIDS & public policy journal 1996;11(3):144-7.
1996: Des Jarlais D C; Friedman S R
HIV epidemiology and interventions among injecting drug users.
International journal of STD & AIDS 1996;7 Suppl 2():57-61.
1995: Perlman D C; Salomon N; Perkins M P; Yancovitz S; Paone D; Des Jarlais D C
Tuberculosis in drug users.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(5):1253-64.
1995: Des Jarlais D C; Paone D; Friedman S R; Peyser N; Newman R G
Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs.
American journal of public health 1995;85(11):1577-84.
1995: Friedman S R; Jose B; Deren S; Des Jarlais D C; Neaigus A
Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium.
American journal of epidemiology 1995;142(8):864-74.
1995: Des Jarlais D C; Hagan H; Friedman S R; Friedmann P; Goldberg D; Frischer M; Green S; Tunving K; Ljungberg B; Wodak A
Maintaining low HIV seroprevalence in populations of injecting drug users.
JAMA : the journal of the American Medical Association 1995;274(15):1226-31.
1995: Wolfe H; Marmor M; Maslansky R; Nichols S; Simberkoff M; Des Jarlais D; Moss A
Tuberculosis knowledge among New York City injection drug users.
American journal of public health 1995;85(7):985-8.
1995: Des Jarlais D C; Friedman S R; Friedmann P; Wenston J; Sotheran J L; Choopanya K; Vanichseni S; Raktham S; Goldberg D; Frischer M
HIV/AIDS-related behavior change among injecting drug users in different national settings.
AIDS (London, England) 1995;9(6):611-7.
1995: Paone D; Caloir S; Shi Q; Des Jarlais D C
Sex, drugs, and syringe exchange in New York City: women's experiences.
Journal of the American Medical Women's Association (1972) 1995;50(3-4):109-14.
1995: Paone D; Des Jarlais D C; Caloir S; Clark J; Jose B
Operational issues in syringe exchanges: the New York City tagging alternative study.
Journal of community health 1995;20(2):111-23.
1995: Paone D; Des Jarlais D C; Gangloff R; Milliken J; Friedman S R
Syringe exchange: HIV prevention, key findings, and future directions.
The International journal of the addictions 1995;30(12):1647-83.
1994: Des Jarlais D C; Paone D; Friedman S R; Peyser N; Newman R G
Regulating syringe exchange programs: a cautionary note.
JAMA : the journal of the American Medical Association 1994;272(6):431-2.
1994: Titus S; Marmor M; Des Jarlais D; Kim M; Wolfe H; Beatrice S
Bleach use and HIV seroconversion among New York City injection drug users.
Journal of acquired immune deficiency syndromes 1994;7(7):700-4.
1994: Curtis R; Friedman S R; Neaigus A; Jose B; Goldstein M; Des Jarlais D C
Implications of directly observed therapy in tuberculosis control measures among IDUs.
Public health reports (Washington, D.C. : 1974) 1994;109(3):319-27.
1994: Des Jarlais D C
The 1993 Okey Memorial Lecture. Cross-national studies of AIDS among injecting drug users.
Addiction (Abingdon, England) 1994;89(4):383-92.
1994: Friedman P; Des Jarlais D C; Peyser N P; Nichols S E; Drew E; Newman R G
Retention of patients who entered methadone maintenance via an interim methadone clinic.
Journal of psychoactive drugs 1994;26(2):217-21.
1994: Des Jarlais D C; Choopanya K; Vanichseni S; Plangsringarm K; Sonchai W; Carballo M; Friedmann P; Friedman S R
AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok.
American journal of public health 1994;84(3):452-5.
1994: Des Jarlais D C
Self-help and science in the treatment of addiction.
Journal of substance abuse treatment 1994;11(2):109-10.
1994: Friedman S R; Jose B; Neaigus A; Goldstein M; Curtis R; Ildefonso G; Mota P; Des Jarlais D C
Consistent condom use in relationships between seropositive injecting drug users and sex partners who do not inject drugs.
AIDS (London, England) 1994;8(3):357-61.
1994: Dubin N; Berman S; Marmor M; Tindall B; Des Jarlais D; Kim M
Estimation of time since infection using longitudinal disease-marker data.
Statistics in medicine 1994;13(3):231-44.
1994: Des Jarlais D C; Friedman S R; Sotheran J L; Wenston J; Marmor M; Yancovitz S R; Frank B; Beatrice S; Mildvan D
Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
JAMA : the journal of the American Medical Association 1994;271(2):121-7.
1994: Neaigus A; Friedman S R; Curtis R; Des Jarlais D C; Furst R T; Jose B; Mota P; Stepherson B; Sufian M; Ward T
The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection.
Social science & medicine (1982) 1994;38(1):67-78.
1994: Marmor M; Titus S; Wolfe H; Krasinski K; Maslansky R; Simberkoff M; Beatrice S; Nichols S; Des Jarlais D C
Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs.
AIDS research and human retroviruses 1994;10 Suppl 2():S207-13.
1993: Jose B; Friedman S R; Neaigus A; Curtis R; Grund J P; Goldstein M F; Ward T P; Des Jarlais D C
Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users.
AIDS (London, England) 1993;7(12):1653-60.
1993: Des Jarlais D C; Friedman S R; Marmor M; Mildvan D; Yancovitz S; Sotheran J L; Wenston J; Beatrice S
CD4 lymphocytopenia among injecting drug users in New York City.
Journal of acquired immune deficiency syndromes 1993;6(7):820-2.
1993: Vanichseni S; Des Jarlais D C; Choopanya K; Friedmann P; Wenston J; Sonchai W; Sotheran J L; Raktham S; Carballo M; Friedman S R
Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States.
AIDS (London, England) 1993;7(6):887-91.
1993: Wolfe H; Marmor M; Moss A; Des Jarlais D
Tuberculosis beliefs among New York City injecting drug users.
Lancet 1993;341(8861):1658-9.
1992: Des Jarlais D C; Wenston J; Friedman S R; Sotheran J L; Maslansky R; Marmor M; Yancovitz S; Beatrice S
Implications of the revised surveillance definition: AIDS among New York City drug users.
American journal of public health 1992;82(11):1531-3.
1992: Des Jarlais D C; Friedman S R; Choopanya K; Vanichseni S; Ward T P
International epidemiology of HIV and AIDS among injecting drug users.
AIDS (London, England) 1992;6(10):1053-68.
1992: Abdul-Quader A S; Des Jarlais D C; Tross S; McCoy E; Morales G; Velez I
Outreach to injecting drug users and female sexual partners of drug users on the lower east side of New York City.
British journal of addiction 1992;87(5):681-8.
1992: Des Jarlais D C; Casriel C; Friedman S R; Rosenblum A
AIDS and the transition to illicit drug injection--results of a randomized trial prevention program.
British journal of addiction 1992;87(3):493-8.
1992: Friedman S R; Neaigus A; Des Jarlais D C; Sotheran J L; Woods J; Sufian M; Stepherson B; Sterk C
Social intervention against AIDS among injecting drug users.
British journal of addiction 1992;87(3):393-404.
1992: Des Jarlais D C; Wenston J; Friedman S R; Sotheran J L; Maslansky R; Marmor M
Crack cocaine use in a cohort of methadone maintenance patients.
Journal of substance abuse treatment 1992;9(4):319-25.
1992: Vanichseni S; Choopanya K; Des Jarlais D C; Plangsringarm K; Sonchai W; Carballo M; Friedmann P; Friedman S R
HIV testing and sexual behavior among intravenous drug users in Bangkok, Thailand.
Journal of acquired immune deficiency syndromes 1992;5(11):1119-23.
1992: Friedman S R; Stepherson B; Woods J; Des Jarlais D C; Ward T P
Society, drug injectors, and AIDS.
Journal of health care for the poor and underserved 1992;3(1):73-89; discussion 90-2.
1991: Choopanya K; Vanichseni S; Des Jarlais D C; Plangsringarm K; Sonchai W; Carballo M; Friedmann P; Friedman S R
Risk factors and HIV seropositivity among injecting drug users in Bangkok.
AIDS (London, England) 1991;5(12):1509-13.
1991: Des Jarlais D C; Abdul-Quader A; Tross S
The next problem: maintenance of AIDS risk reduction among intravenous drug users.
The International journal of the addictions 1991;26(12):1279-92.
1991: Frank B; Des Jarlais D C; Marel R; Schmeidler J; Maranda M
The epidemiology of cocaine use in New York State.
The Mount Sinai journal of medicine, New York 1991;58(5):406-11; discussion 437-42.
1991: Yancovitz S R; Des Jarlais D C; Peyser N P; Drew E; Friedmann P; Trigg H L; Robinson J W
A randomized trial of an interim methadone maintenance clinic.
American journal of public health 1991;81(9):1185-91.
1991: Des Jarlais D C
Drug abuse.
Bulletin of the New York Academy of Medicine 1991;67(1):43-8.
1991: Des Jarlais D C; Abdul-Quader A; Minkoff H; Hoegsberg B; Landesman S; Tross S
Crack use and multiple AIDS risk behaviors.
Journal of acquired immune deficiency syndromes 1991;4(4):446-7.
1991: Friedman S R; Des Jarlais D C
HIV among drug injectors: the epidemic and the response.
AIDS care 1991;3(3):239-50.
1991: Des Jarlais D C
Potential cofactors in the outcomes of HIV infection in intravenous drug users.
NIDA research monograph 1991;109():115-23.
1990: Abdul-Quader A S; Tross S; Friedman S R; Kouzi A C; Des Jarlais D C
Street-recruited intravenous drug users and sexual risk reduction in New York City.
AIDS (London, England) 1990;4(11):1075-9.
1990: Casadonte P P; Des Jarlais D C; Friedman S R; Rotrosen J P
Psychological and behavioral impact among intravenous drug users of learning HIV test results.
The International journal of the addictions 1990;25(4):409-26.
1990: Kleinman P H; Goldsmith D S; Friedman S R; Hopkins W; Des Jarlais D C
Knowledge about and behaviors affecting the spread of AIDS: a street survey of intravenous drug users and their associates in New York City.
The International journal of the addictions 1990;25(4):345-61.
1990: Friedman S R; Des Jarlais D C; Sterk C E; Sotheran J L; Tross S; Woods J; Sufian M; Abdul-Quader A
AIDS and the social relations of intravenous drug users.
The Milbank quarterly 1990;68 Suppl 1():85-110.
1990: Casriel C; Des Jarlais D C; Rodriguez R; Friedman S R; Stepherson B; Khuri E
Working with heroin sniffers: clinical issues in preventing drug injection.
Journal of substance abuse treatment 1990;7(1):1-10.
1990: Neaigus A; Sufian M; Friedman S R; Goldsmith D S; Stepherson B; Mota P; Pascal J; Des Jarlais D C
Effects of outreach intervention on risk reduction among intravenous drug users.
AIDS education and prevention : official publication of the International Society for AIDS Education 1990;2(4):253-71.
1989: Novick D M; Trigg H L; Des Jarlais D C; Friedman S R; Vlahov D; Kreek M J
Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City.
Journal of medical virology 1989;29(3):181-5.
1989: Friedman S R; Sterk C; Sufian M; Des Jarlais D C
Will bleach decontaminate needles during cocaine binges in shooting galleries?
JAMA : the journal of the American Medical Association 1989;262(11):1467.
1989: Des Jarlais D C; Friedman S R
AIDS and i.v. drug use.
Science (New York, N.Y.) 1989;245(4918):578.
1989: Friedman S R; Des Jarlais D C; Neaigus A; Abdul-Quader A; Sotheran J L; Sufian M; Tross S; Goldsmith D
AIDS and the new drug injector.
Nature 1989;339(6223):333-4.
1989: Des Jarlais D C; Friedman S R; Novick D M; Sotheran J L; Thomas P; Yancovitz S R; Mildvan D; Weber J; Kreek M J; Maslansky R
HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987.
JAMA : the journal of the American Medical Association 1989;261(7):1008-12.
1988: Stoneburner R L; Des Jarlais D C; Benezra D; Gorelkin L; Sotheran J L; Friedman S R; Schultz S; Marmor M; Mildvan D; Maslansky R
A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City.
Science (New York, N.Y.) 1988;242(4880):916-9.
1988: Novick D M; Des Jarlais D C; Kreek M J; Spira T J; Friedman S R; Gelb A M; Stenger R J; Schable C A; Kalyanaraman V S
Specificity of antibody tests for human immunodeficiency virus in alcohol and parenteral drug abusers with chronic liver disease.
Alcoholism, clinical and experimental research 1988;12(5):687-90.
1988: Novick D M; Pascarelli E F; Joseph H; Salsitz E A; Richman B L; Des Jarlais D C; Anderson M; Dole V P; Nyswander M E
Methadone maintenance patients in general medical practice. A preliminary report.
JAMA : the journal of the American Medical Association 1988;259(22):3299-302.
1988: Des Jarlais D C; Friedman S R; Stoneburner R L
HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention.
Reviews of infectious diseases 1988;10(1):151-8.
1988: Des Jarlais D C; Friedman S R
Gender differences in response to HIV infection.
Advances in biochemical psychopharmacology 1988;44():159-63.
1988: Des Jarlais D C; Friedman S R
HIV infection among persons who inject illicit drugs: problems and prospects.
Journal of acquired immune deficiency syndromes 1988;1(3):267-73.
1988: Des Jarlais D
Current epidemiology of AIDS among i.v. drug users in New York City.
NIDA research monograph 1988;90():311-3.
1988: Des Jarlais D C; Friedman S R
HIV and intravenous drug use.
AIDS (London, England) 1988;2 Suppl 1():S65-9.
1988: Des Jarlais D C; Friedman S R; Sotheran J L; Stoneburner R
The sharing of drug injection equipment and the AIDS epidemic in New York City: the first decade.
NIDA research monograph 1988;80():160-75.
1987: Zolla-Pazner S; Des Jarlais D C; Friedman S R; Spira T J; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J
Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(15):5404-8.
1987: Des Jarlais D C; Friedman S R
HIV infection among intravenous drug users: epidemiology and risk reduction.
AIDS (London, England) 1987;1(2):67-76.
1987: Des Jarlais D C; Friedman S R; Marmor M; Cohen H; Mildvan D; Yancovitz S; Mathur U; el-Sadr W; Spira T J; Garber J
Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users.
AIDS (London, England) 1987;1(2):105-11.
1987: Marmor M; Des Jarlais D C; Cohen H; Friedman S R; Beatrice S T; Dubin N; el-Sadr W; Mildvan D; Yancovitz S; Mathur U
Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City.
AIDS (London, England) 1987;1(1):39-44.
1987: Friedman S R; Sotheran J L; Abdul-Quader A; Primm B J; Des Jarlais D C; Kleinman P; Maugé C; Goldsmith D S; el-Sadr W; Maslansky R
The AIDS epidemic among blacks and Hispanics.
The Milbank quarterly 1987;65 Suppl 2():455-99.
1986: Des Jarlais D C
Locus of control and need for control among heroin users.
NIDA research monograph 1986;74():37-44.
1986: Novick D M; Kreek M J; Des Jarlais D C; Spira T J; Khuri E T; Ragunath J; Kalyanaraman V S; Gelb A M; Miescher A
Antibody to LAV, the putative agent of AIDS, in parenteral drug abusers and methadone-maintained patients: therapeutic, historical, and ethical aspects.
NIDA research monograph 1986;67():318-20.
1986: Des Jarlais D C; Friedman S R; Spira T J; Zolla-Pazner S; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J
A stage model of HTLV-III LAV infection in intravenous drug users.
NIDA research monograph 1986;67():328-34.
1985: Des Jarlais D C; Joseph H; Dole V P; Nyswander M E
Medical maintenance feasibility study.
NIDA research monograph 1985;58():101-10.
1984: Spira T J; Des Jarlais D C; Marmor M; Yancovitz S; Friedman S; Garber J; Cohen H; Cabradilla C; Kalyanaraman V C
Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York.
The New England journal of medicine 1984;311(7):467-8.
1981: Des Jarlais D C; Joseph H; Dole V P
Long-term outcomes after termination from methadone maintenance treatment.
Annals of the New York Academy of Sciences 1981;362():231-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Don Des Jarlais

Research Profile (preview)

Activities & Behaviors

Disorders

Geographic Areas

Organizations

Concepts & Ideas

Procedures

Phenomena

Chemicals & Drugs

Devices

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Don Des Jarlais (preview)

All Publications